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Abstract
Humanized mice, which are generated by transplanting human CD34
+ hematopoietic stem cells into immunodeficient mice,
are expected to be useful for the research on human immune responses. It is reported that antigen-specific T cell responses
occur in immunodeficient mice transplanted with both human fetal thymus/liver tissues and CD34
+ fetal cells, but it remains
unclear whether antigen-specific T cell responses occur in those transplanted with only human CD34
+ hematopoietic stem
cells (HSCs). Here we investigated the differentiation and function of human CD8
+ T cells reconstituted in NOD/SCID/Jak3
2/2
mice transplanted with human CD34
+ HSCs (hNOK mice). Multicolor flow cytometric analysis demonstrated that human CD8
+
T cells generated from the CD34
+ HSCs comprised only 3 subtypes, i.e., CD27
highCD28
+CD45RA
+CCR7
+,
CD27
+CD28
+CD45RA
2CCR7
+,a n dC D 2 7
+CD28
+CD45RA
2CCR7
2 and had 3 phenotypes for 3 lytic molecules, i.e.,
perforin(Per)
2granzymeA(GraA)
2granzymeB(GraB)
2, Per
2GraA
+GraB
2, and Per
lowGraA
+GraB
+. These CD8
+ T cells failed to
produce IFN-c and to proliferate after stimulation with alloantigens. These results indicate that the antigen-specific T cell
response cannot be elicited in mice transplanted with only human CD34
+ HSCs, because the T cells fail to develop normally in
such mice.
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Introduction
Humanized mice are generated by transplanting human CD34
+
hematopoietic stem cells (HSCs) into immunodeficient mice and
are expected to become a useful tool in studies on human T cell
immune responses, infectious diseases, preclinical testing of
vaccines, and new therapeutic strategies. Previous studies showed
long-term human T cell and B cell reconstitution in NOD/SCID/
cc
null immunodeficient mice transplanted with human CD34
+
HSCs (hNOG mice) [1–3]. Human IgM, IgG, and IgA were
detectable in the serum of these mice; and class-switching of
immunoglobulin in human cord blood (CB)-derived B cells
properly occurred in the mice [4–7], indicating that the human
B cells can develop from human CD34
+ HSCs in the hNOG mice
and are functionally competent to produce immunoglobulins in
them. Furthermore, previous studies demonstrated that human
CD4/CD8 double-positive and human CD4/CD8 single positive
T cells were observed in the thymus of the hNOG mice and that
the latter were found in the spleen and peripheral blood of these
animals [3–5,7,8]. These human T cells expressed predominantly
ab T cell receptors in the thymus and the spleen of the recipient,
whereas CD45RA
+ naive T cells were identified in the spleen and
the peripheral blood of the hNOG mice [4,9,10]. These results
suggest the possibility that the human T cells respond to highly
diverse molecules. Additionally, proliferation and IFN-c expres-
sion of EBV-specific human CD8
+ T cells have been demonstrated
in hNOG mice and in Rag2
2/2cc
2/2 mice transplanted with
human CD34
+ HSCs after an EBV infection [8,11]. In contrast,
high-dose injection of EBV caused a fatal lymphoproliferative
disorder in the hNOG mice, whereas lower-dose injection induces
an apparently asymptomatic persistent infection [11]. These
findings suggest that the human T cell responses were not able
to control the replication of EBV in the hNOG mice.
On the other hand, antigen-specific T cell immune responses
had definitely been shown in humanized NOD/SCID mice
established by transplanting human fetal thymus/liver tissues and
CD34
+ fetal liver cells into them (BLT mice) [12–16]. However,
there are no studies providing reliable evidence as to whether or
not antigen-specific T cell responses are induced in humanized
mice established by transplanting only human CD34
+ HSCs into
immunodeficient mice.
The phenotypic analysis of human T cells in humanized mice is
useful to clarify their differentiation and effector function, because
the phenotypic classification of human T cells reflects their
differentiation and effector function. Previous studies demonstrat-
ed that human CD8
+ T cells change the expression levels of co-
PLoS ONE | www.plosone.org 1 October 2010 | Volume 5 | Issue 10 | e13109stimulatory molecules (CD27, CD28, and CD45RA) [17–19] and
chemokine receptor CCR7 on their surface according to their
differentiation and maturation [20,21]. The phenotypic analysis
of human CD8
+ T cells showed that CD27
highCD28
+CD45-
RA
+CCR7
+, CD27
+CD28
+CD45RA
2CCR7
+, CD27
+CD28
+-
CD45RA
2CCR7
2, CD27
lowCD28
2CD45RA
+/2CCR7
2,a n d
CD27
2CD28
2CD45RA
+/2CCR7
2 have characteristics of naive,
central memory, early effector memory, late effector memory, and
effector CD8
+ T cells, respectively [22,23]. Moreover, human CD8
+
T cells express 3 key cytolytic effector molecules, i.e., perforin (Per),
granzyme A (GraA), and granzyme B (GraB) in response to their
differentiation [24]. Five subpopulations of human CD8
+ Tc e l l s
defined by these cytolytic molecules exist and appear sequentially
during CD8
+ T cell differentiation: Per
2GraA
2GraB
2,P e r
2GraA
+-
GraB
2,P e r
lowGraA
+GraB
2,P e r
lowGraA
+GraB
+,a n dP e r
highGraA
+-
GraB
+ [25]. Thus, the functional subsets of human CD8
+ Tc e l l sc a n
be identified by the phenotypic classification and the expression of
these 3 cytolytic molecules [25]. By using these classifications of
human CD8
+T cells, the differentiation and function of human CD8
+
T cells reconstituted in humanized mice can be clarified in detail. A
previous study showed that the CD45RA
+CCR7
2 subset were
detected in hNOG mice [10], suggesting the possibility that human
CD8
+ T cells can be differentiated in the mice. However, since this
study did not demonstrated the existence of effector subset,
CD27
2CD28
2CD45RA
+/2CCR7
2, it still remainsunclearifhuman
CD8
+ T cells can be differentiated into effector cells in hNOG mice.
In the present study, to clarify antigen-specific human CD8
+ T
cell responses in immunodeficient mice transplanted with only
human CD34
+ HSCs, we established NOD/SCID/JAK3
2/2
(NOK) mice transplanted with human CD34
+ HSCs (hNOK
mice) and investigated the differentiation and function of human
CD8
+ T cells reconstituted in these mice. Especially, we focused
on performing phenotypic classification based on the expression of
the above-mentioned effector molecules and the alloreactivity of
human CD8
+ T cells reconstituted in the mice.
Results
Reconstitution of human T cells in hNOK mice
hNOK mice were established by transplanting human CD34
+
HSCs isolated from human CB into the liver of newborn NOK
mice. In order to investigate the reconstitution of the human
immune system in these mice, we obtained PBMC from the mice
at 10, 12 and 17 weeks after the transplantation and then analyzed
them by using flow cytometry for detecting human T and B cells.
As shown in Table 1, the cells expressing common human
leukocyte antigen CD45 (hCD45
+) were found in all hNOK mice
at 10 weeks after the transplantation (n=31). Among the hCD45
+
cells, human B cells, identified by the expression of CD19, were
observed in all hNOK mice, whereas human T cells, identified by
the expression of CD3, were observed in approximately 60% of
the mice (Table 1). In the mice carrying human T cells, the
proportion of human T cells gradually increased from 10 to 17
weeks after the transplantation and reached a level at 17 weeks
similar to the proportion of CD8
+ T cells in the human adult
PBMC population (Figure 1A and 1B). The human T cells
obtained during the period of 10-17 weeks post transplantation
included both human CD4
+ and CD8
+ T cells (Figure 1C), though
the ratio of human CD4/CD8 T cells gradually increased from the
10 to 17 weeks (Figure 1D). These results show that human CD8
+
and CD4
+ T cells were generated and maintained in the mice.
Phenotypic analysis of human T cells reconstituted in
hNOK mice
Human peripheral CD8
+ T cells are classified into the following 5
major populations based on their expression of 4 cell-surface
Table 1. Proportion of human immune cells in hNOK mice.
% nucleated cells % nucleated cells
Cord blood hCD45 gated Cord blood hCD45 gated
Mouse No. hCD45
+ CD3
+ CD19
+ Mouse No. hCD45
+ CD3
+ CD19
+
Donor 1 1 12.8 0.0 54.6 Donor 4 1 62.1 46.7 48.3
2 32.7 32.3 61.8 2 37.4 37.0 58.8
3 55.1 55.7 40.3 3 57.4 23.3 67.8
4 59.1 0.0 89.3 4 47.3 45.0 49.2
5 5.1 0.5 94.9 5 21.4 0.0 91.0
6 34.2 38.0 57.5 6 37.1 33.7 57.5
Donor 2 1 45.8 0.1 67.9 Donor 5 1 32.1 0.2 95.0
2 35.1 13.1 57.9 2 10.3 0.0 92.9
3 55.6 49.7 40.6 3 64.8 30.2 67.3
4 19.3 0.0 65.5 4 44.2 0.0 96.5
5 69.4 39.5 48.4 5 3.5 0.0 81.0
Donor 3 1 5.8 0.4 76.2 Donor 6 1 6.6 5.2 81.0
2 18.9 47.0 43.4 2 7.7 81.3 13.2
3 37.6 84.1 11.7 Donor 7 1 10.5 34.1 60.7
4 10.7 0.2 79.7 2 50.3 42.2 54.0
5 58.4 73.6 22.6
For generation of hNOK mice, human CD34
+ cells derived from 7 cord blood samples were transplanted into newborn NOK mice. PBMC of the hNOK mice were
analyzed for the engraftment of human immune cells at 10 weeks after the transplantation (n=31).
doi:10.1371/journal.pone.0013109.t001
Human T Cells in hNOK Mice
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highCD28
+CD45RA
+CCR7
+ (naive subset), CD27
+
CD28
+CD45RA
2CCR7
+ (central memory subset), CD27
+CD28
+
CD45RA
2CCR7
2 (early effector memory subset), CD27
lowCD28
2
CD45RA
+/2CCR7
2 (late effector memory subset), and CD27
2
CD28
2CD45RA
+/2CCR7
2 (effector subset) [22,23]; whereas
human peripheral CD4
+ T cells are also classified into 5 major
populations by the same 4 cell-surface markers, i.e., CD27
+CD28
+
CD45RA
+CCR7
+ (naive subset), CD27
+CD28
+CD45RA
2CCR7
+
(central memory subset), CD27
+CD28
+CD45RA
2CCR7
2 (Th0
effector memory subset), CD27
-CD28
+CD45RA
2CCR7
2 (Th1/2
effector memory subset), and CD27
2CD28
2CD45RA
2CCR7
2
(effector subset) [26]. To examine the differentiation of human T
cells reconstituted in the hNOK mice, we analyzed the phenotype of
human T cells among PBMC from the mice at 17 weeks after the
transplantation andthat ofT cellsamongPBMCfromadult humans
for comparison. Representative results for an individual hNOK
mouse and an adult human are shown in Figure 2A; and a summary
of the findings, in Figure 2B. The reconstituted human CD8
+ Tc e l l
population included naive (39.7626.9%), central memory
(18.969.7%), and early effector memory (18.4615.9%) subsets.
Late effector memory (0.961.6%) and effector (0.862.6%) subsets
were hardly detected in the mice. These results suggest that the
human CD8
+ T cells did notdifferentiate into late effector or effector
human T cells in the mice.
The phenotypic analysis of the reconstituted human CD4
+ T
cell population in the PBMC from the mice revealed that it
included naive (27.5623.0%), central memory (31.2610.1%),
Th0 effector memory (28.1618.8%), and Th1/2 effector memory
(9.0611.4%) subsets. The effector (0.0660.15%) subset was
hardly detected, suggesting that the human CD4
+ T cells did
not differentiate into effector T cells in these mice.
Expression of 3 cytolytic effector molecules in
reconstituted human CD8
+ T cells
Human peripheral CD8
+ T cells are classified into the following
5 major populations based on their expression levels of 3 effector
molecules: Per
2GraA
2GraB
2, Per
2GraA
+GraB
2, Per
lowGraA
+
GraB
2, Per
lowGraA
+GraB
+, and Per
highGraA
+GraB
+ [25]. To
investigate the effector function of the human CD8
+ T cells
reconstituted in the hNOK mice, we examined the expression of
these effector molecules in human CD8
+ T cells among
splenocytes from the mice. A representative result and summary
of the analysis for 6 hNOK mice as well as for PBMC from 3 adult
humans are shown in Figure 3A and 3B, respectively. The human
CD8
+ T cells included Per
2GraA
2GraB
2, Per
2GraA
+GraB
2,
and Per
lowGraA
+GraB
+ cells. But they did not include Per
low
GraA
+GraB
2 or Per
highGraA
+GraB
+ ones, though the latter were
found among human adult PBMC. These results indicate that the
reconstituted human CD8
+ T cells did not have effector function
in the mice and that the human CD8
+ T cells did not differentiate
into effector cells in the mice.
Ability of reconstituted human CD8
+ T cells to produce
cytokines
Human CD8
+ T cells producing IL-2 but not IFN-c are mainly
found in naive and central memory CD8
+ T cell populations,
whereas IFN-c and TNF-a are mainly produced by effector
memory and effector CD8
+ T cells among human PBMC [22,27].
Figure 1. Flow cytometric analysis of human T cells reconstituted in hNOK mice. (A) A representative result for hCD45
+CD3
+ T cells and
hCD45
+CD19
+ B cells among PBMC from hNOK mice at 10, 12, and 17 weeks after the transplantation. (B) Summarized results showing hCD45
+CD3
+ T
cell proportion in PBMC from hNOK mice (n=20) at 10, 12 and 17 weeks. (C) A representative result for human CD4
+ and CD8
+ T cell proportions in
PBMC from hNOK at 10, 12 and 17 weeks after the transplantation. (D) Summarized results showing human CD4/CD8 T cell ratio for PBMC from hNOK
mice at 10, 12, and 17 weeks. Human PBMC from healthy adult individuals (n=4) are shown as a control. Bar graph data are shown as the mean 6
SEM of 7 independent experiments. *, p,0.05, human PBMC vs. hNOK mouse PBMC.
doi:10.1371/journal.pone.0013109.g001
Human T Cells in hNOK Mice
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+ T cells reconstituted
in the hNOK mice to produce these cytokines, we stimulated
splenocytes isolated from these mice with PMA and ionomycin in
vitro and measured the production of the above cytokines. A
representative result and summary of the analysis for 12 hNOK
mice are given in Figure 4A and 4B, respectively. The human
CD8
+ T cells reconstituted in the mice produced IFN-c, TNF-a,
and IL-2 (Figure 4A). The frequency of IFN-c-producing CD8
+ T
cells positively correlated with that of the effector memory
(CD27
+CD28
+CD45RA
2CCR7
2 plus CD27
lowCD28
2CD45
RA
+/2CCR7
2) subset, whereas the frequency of IL-2
+IFN-
c
2TNF-a
2-producing CD8
+ T cells negatively correlated with
that of effector memory subset (Figure 4B). These results indicate
that the human CD8
+ T cells had the ability to produce these
cytokines in the mice.
Alloreactivity of human CD8
+ T cells reconstituted in
hNOK mice
It is well known that 0.1–10% of human T-cell repertoire react
with alloantigens compared with a frequency of ,1/100,000 for
foreign antigens in humans [28,29]. We investigated alloreactivity
of human CD8
+ T cells reconstituted in hNOK mice to clarify the
responsiveness of antigen-specific human CD8
+ T cells. We
immunized hNOK mice with irradiated human PBMC from a
healthy donor with HLA-A*2402/A*2402, B*5201/B*5901, and
DRB1*1502/DRB1*0405 (allo-PBMC) (n=4) and analyzed the
phenotype of human CD8
+ T cells reconstituted in the mice on 7
days or 31 days after the PBMC injection. Flow cytometric
analysis demonstrated that CD27
2CD28
2CD45RA
+/2CCR7
2
effector CD8
+ T cell subsets and Per
highGraA
+GraB
+ cells were
not induced in the mice on 7 days and 31 days after the PBMC
injection (Figures S1A and S1B). We further analyzed the ability of
the human CD8
+ T cells to produce IFN-c after allo-PBMC
stimulation. The splenocytes from the mice obtained at 31 days
after injection of the irradiated PBMC into the mice were cultured
with the irradiated PBMC in vitro for 7 days, and then the ability of
the human CD8
+ T cells to produce IFN-c was measured after
stimulation with the irradiated PBMC. As shown in Figure 5A, the
human CD8
+ T cells and the CD8
2 T cells (mostly CD4
+ T cells)
reconstituted in the mice did not produce IFN-c, suggesting that
both CD8
+ T cells and CD4
+ T cells could not recognize
alloantigen. In addition, we analyzed the ability of the human
CD8
+ T cells to proliferate after stimulation with alloantigens. The
splenocytes of the mice on 31 days were labeled with CFSE
(carboxyfluorescein diacetate N-succinimidyl ester); and the cells
were cultured for 3 days with irradiated 721.221 cells expressing
HLA-A*2402 (.221-A*2402) or irradiated 721.221 expressing
HLA-B*5201 (.221-B*5201) in vitro. As shown in Figure 5B, the
human CD8
+ T cells and the CD8
2 T cells (mostly CD4
+ T cells)
reconstituted in the mice did not proliferate in response to.221-
A*2402 or. 221-B*5201 cells. In addition, they did not proliferate
in response to splenocytes of C57BL/6(H-2
b) or Balb/c (H-2
d)
mice (data not shown). These results together indicate that the
human CD8
+ T cells could not recognize alloantigens in the mice.
Figure 2. Phenotypic classification of human CD8
+ T cells reconstituted in hNOK mice. Human T cells among PBMC from hNOK mice at 17
weeks after the transplantation were analyzed for the expression of the following cell-surface markers: CD4, CD8, CD27, CD28, CD45RA, and CCR7. (A)
A representative result of 5-color flow cytometric analysis of the human CD8
+ T cell population among PBMC from a hNOK mouse (right data) and an
adult human (left data). (B) Summarized results showing frequency of subsets among the human CD8
+ T cells isolated from the PBMC from hNOK
mice (n=20, right data) and human adult individuals (n=4, left data). (C) A representative result of 5-color flow cytometric analysis of human CD4
+ T
cell population in PBMC from hNOK mice (right data) and a human adult individual (left data). (D) Summarized result showing human CD4
+ T cell
proportion in PBMC from hNOK mice (n=20, right data) and human adult individuals (n=4, left data). Each symbol represents 1 mouse; the mean
value is shown as a horizontal solid line. *, p,0.05; **, p,0.01, human PBMC vs. hNOK mice PBMC.
doi:10.1371/journal.pone.0013109.g002
Figure 3. Expression of 3 cytolytic effector molecules of human CD8
+ T cells reconstituted in hNOK mice. Human CD8
+ T cells among
splenocytes of hNOK mice were analyzed for the expression of 3 cytolytic effector molecules: Per, Gra A, and Gra B. (A) A representative result
showing co-expression of 3 cytolytic effector molecules in human CD8
+ T cells from a hNOK mouse (lower data) and a human adult individual (upper
data). (B) Summarized result for the expression of 3 the cytolytic effector molecules in human CD8
+ T cells from hNOK mice (n=6) and human adult
individuals (n=3).
doi:10.1371/journal.pone.0013109.g003
Human T Cells in hNOK Mice
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+ T cells reconstituted in hNOK mice. Splenocytes from hNOK mice were cultured with PMA
and ionomycin for 6 hours and then the production of IFN-c, TNF-a, and IL-2 cytokines by human CD8
+ T cells was measured by flow cytometry. (A) A
representative result for cytokine production by human CD8
+ T cells from a hNOK mouse (lower data) and a human adult individual (upper data). (B)
Correlation between frequency of IFN-c-, TNF-a-, and IL-2
+IFN-c
2TNF-a
2 (IL-2
single+)-producing CD8
+ T cells and that of effector memory
(CD27
+CD28
+CCR7
2CD45RA
2 plus CD27
lowCD28
2CD45RA
+/2CCR7
2) CD8
+ T cell subset (n=12).
doi:10.1371/journal.pone.0013109.g004
Figure 5. Alloreactivity of human CD8
+ T cells reconstituted in hNOK mice. The hNOK mice were immunized for 31 days with irradiated
human PBMC (allo-hPBMC) from a healthy donor with HLA-A*2402/A*2402, HLA-B*5201/B*5901, and HLA-DRB1*1502/DRB1*0405 (immunized mice)
or PBS (un-immunized mice). The splenocytes of each hNOK mice were harvested, and the cells were stained by using anti-human CD45, anti-human
CD3, and anti-human CD8 mAbs. (A) Human adult PBMC from a healthy donor with HLA-A*2601/A*2403, HLA-B*3501/B*5101, and HLA-DRB1*0405/
DRB1*0405 were cultured with the allo-hPBMC or the self-hPBMC for 7 days in vitro, and a representative result showing the IFN-c production by the
human CD8
+ T cells and the human CD8
2 T cells is shown as a control (upper data). The splenocytes from the immunized hNOK mice were cultured
with the allo-hPBMC or self-CB for 7 days in vitro, and a representative result for IFN-c production by the human CD8
+ T cells and the human CD8
2 T
cells is shown (lower data). (B) Splenocytes from the immunized hNOK mice were cultured with irradiated 721.221 cells expressing HLA-A*2402 (.221-
A*2402) or irradiated 721.221 expressing HLA-B*5201 (.221-B*5201) for 3 days in vitro, and a representative result for the proliferation of the human
CD8
+ T cells or the human CD8
2 T cells is shown. One representative experiment from 3 experiments is shown.
doi:10.1371/journal.pone.0013109.g005
Human T Cells in hNOK Mice
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It had remained unknown whether antigen-specific human T
cell responses can be elicited in immunodeficient mice transplant-
ed with only human CD34
+ HSCs. In the present study, we
analyzed the differentiation of the reconstituted human T cells and
the function of the human CD8
+ T cells stimulated by alloantigens
in hNOK mice. Because human T cells express 4 cell-surface
markers (CD27, CD28, CD45RA, and CCR7) and 3 cytolytic
molecules (GraA, GraB, and Per) at different levels according to
their stage of differentiation and maturation [22,23,25], the
analysis of phenotype and effector molecule expression in the
reconstituted human T cells is useful to clarify their differentiation
status and effector function. We demonstrated that the
CD27
lowCD28
2CD45RA
+/2CCR7
2 (late effector memory) and
the CD27
2CD28
2CD45RA
+/2CCR7
2 (effector) subsets did not
exist among the human CD8
+ T cells from the hNOK mice. In
addition, the reconstituted human CD8
+ T cells did not include
the Per
highGraA
+GraB
+ (effector) cells. These results suggest that
the reconstituted human CD8
+ T cells did not have their effector
function in vivo. On the other hand, the reconstituted human CD8
+
T cells included the CD27
+CD28
+CD45RA
2CCR7
2 (early
effector memory) subsets in the hNOK mice, suggesting that the
human CD8
+ T cells could differentiate into memory T cells in the
hNOK mice in response to some stimulation. Although early
effector memory CD8
+ T cells among the human adult CD8
+ T
cell population include Per
lowGraA
+GraB
2 cells [25], the
reconstituted human CD8
+ T cells did not include the Per
low-
GraA
+GraB
2 ones. This finding suggests that some population of
early effector memory CD8
+ T cells in the mice were defective and
could not express Per in the course of their differentiation. These
results further suggest that the human CD8
+ T cells did not have
their effector function in the hNOK mice. On the other hand, the
reconstituted human CD8
+ T cells showed the ability to produce
cytokines similar to that of human adult CD8
+ T cells.
The linear differentiation model supports the idea that the naive
T cells differentiate directly into effector cells during the acute
phase of the response and that following contraction in the
numbers of the effector cells at the end of the primary response,
effector memory and central memory T cells become detectable
[30]. However, the human CD8
+ T cells reconstituted in the
hNOK mice showed the lack of Per expression and Per
lowGraA
+-
GraB
2 subset, implying that the cells could not differentiate into
effector cells and subsequently differentiate into memory cells. The
results of phenotypic analysis and effector molecule expression of
the reconstituted human CD8
+ T cells in the hNOK mice support
the idea that the human CD8
+ T cells asymmetrically divided into
long-lived memory cells [30,31].
A previous study demonstrated the presence of alloantigen-
specific cytotoxic human T cell clones in hNOG mice [5].
However, the data from that study do not exactly reflect T cell
responses in vivo; because alloantigen-specific human CD8
+ T cell
clones were established from the spleen cells of the mice cultured
with allogeneic target cells in vitro. The frequency of the human
alloreactive T cell repertoire was evaluated to reflect between
0.1% and 10% of the total T cell population, whereas that of T
cells specific for foreign antigen is ,1/100,000 [28,29]. Since the
reconstituted human CD8
+ T cells did not respond to alloantigen
in the hNOK mice, these reconstituted human CD8
+ T cells may
not have a foreign antigen-specific function in vivo. This result
implies that the reconstituted human CD8
+ T cells did not have
the appropriate T cell receptor (TCR) repertoire against foreign
antigens, because the human CD8
+ T cells were educated by
mouse MHC-peptide complexes in the thymus. CD8 co-receptors
bind with a nonpolymorphic region within the a3 domain of class
I MHC proteins, and their binding has species specificity [32–36].
Considering that human CD8 molecules fail to bind to murine
MHC, the human CD8
+ T cells in immunodeficient mice
transplanted with only human CD34
+ HSCs are not educated in
the murine thymus.
There are several reports that antigen-specific responses are
detectable in BLT mice infected with EBV or HIV [12,14,16].
Furthermore, the BLT mice produce high levels of human IgM
and IgG antibodies and mediate strong immune responses in vivo,
as demonstrated by skin xenograft rejection [13]. These results
suggest that the reconstituted human T cells educated in the
human thymus can have appropriate antigen-specific function in
mice. A recent study demonstrated that the human CD8
+ T cells
reconstituted in HLA transgenic NOG mice transplanted with
only human CD34
+ HSCs expressed IFN-c production and EBV-
specific cytolytic activity in response to an EBV infection [37,38],
suggesting that the reconstituted human T cells educated by
human HLA class I molecules on mouse thymus cells have
appropriate effector function in the mice.
In the present study, we demonstrated impaired differentiation
of human CD8
+ T cells in the hNOK mice established with only
human CD34
+ T cells and lack of ability to induce the effector
function. Previous studies of hNOG mice showed very weak
immune responses to viral antigens [8,9,11]. Thus both hNOK
and hNOG mice seems to have no or weak ability in HLA-
restricted T cell responses although it is unclear whether some
differences exist in human T cell function between 2 humanized
mice. HLA transgenic immunodeficient mice are expected to be
useful for the generation of a good mouse model having human
immunity.
Materials and Methods
Establishment of humanized mice
The NOK mouse strain was established by backcrossing
JAK3
2/2 mice with the NOD.Cg-Prkdcscid strain for 10
generations. The NOK mice were maintained under specific
pathogen-free conditions in the Center for Animal Resources and
Development. Animal experiments were conducted according to
the Regulation for Animal Experiments in Kumamoto University
(Approval ID, C22-168: Analysis of immune responses against
viral diseases by using humanized and HLA transgenic mice).
Human CB was purchased from Riken Cell Bank (Tsukuba,
Japan). Human CD34
+ cells were isolated from human CB by
using a Direct CD34 Progenitor Cell Isolation Kit and an MS
Column (Miltenyi Biotec, Gladbach, Germany). The usual purity
of the human CD34
+ cells was approximately 95%. The hNOK
mice were generated by injecting the isolated human CD34
+ cells
(5610
4 cells/mouse) into the liver of newborn NOK mice.
Blood samples
Human blood samples were taken from healthy adult
individuals. Peripheral blood mononuclear cells (PBMC) were
isolated from the blood by using Ficoll-Paque PLUS (GE
Healthcare, Uppsala, Sweden).
Cell lines
721.221 cells are human B cell lines lacking HLA class I but not
HLA class II [39]. 721.221 cells expressing HLA-A*2402 (.221-
A*2402) and those expressing HLA-B*5201 (.221-B*5201) were
generated by transfecting of HLA-A*2402 and HLA-B*5201 genes
into 721.221 cells, respectively.
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Human leukocytes reconstituted in hNOK mice were stained
with various combinations of monoclonal antibodies (mAbs):
FITC-labeled anti-mouse CD45 (mCD45), PECy7-labeled human
CD45 (hCD45), allophycocyanin-labeled anti-CD4, allophycocya-
nin, Cy7-labeled anti-CD4, AmCyan-labeled anti-CD8, Pacific
blue-labeled anti-CD8, PE-labeled anti-CD19, FITC-labeled anti-
Per, PE-labeled anti-GraA, Alexa647-labeled anti-GraB, PE-Cy7-
labeled anti-CCR7, FITC-labeled anti-CD45RA, PE-labeled anti-
CD28, allophycocyanin-Cy7-labeled anti-CD27, FITC-labeled
IFN-c and PE-Cy7-labeled TNF-a mAbs, all were purchased
from BD Biosciences (San Diego, CA). ECD-labeled anti-CD3
mAb was obtained from Beckman Coulter (Fullerton, CA); and
allophycocyanin-labeled IL-2 mAb, from e-bioscience (San Diego,
CA). To analyze the phenotype of human T cells reconstituted in
the hNOK mice, we first stained the human T cells with anti-
CCR7 mAb for 30 min at room temperature, and subsequently
with specific antibody against surface markers at 4uC for 30 min.
The cells were washed twice with PBS containing 10% fetal calf
serum (FCS; Sigma-Aldrich, St. Louis, MO). To analyze the
intracellular expression of IFN-c, Per, GraA, and GraB, we fixed
cells with 4% paraformaldehyde PBS at 4uC for 20 min, and then
made them permeable by incubating them at 4uC for 10 min in
PBS containing 0.1% saponin (Sigma-Aldrich) and 20% FCS
(permeabilizing buffer). The cells were then stained with anti-IFN-
c, anti-Per, anti-GraA, and anti-GraB mAbs at 4uC for 20 min.
Finally, the stained cells were washed 3 times in the permeabilizing
buffer at 4uC. The stained cells were analyzed by using a
FACSCant II flow cytometer (BD Biosciences, San Jose, CA). All
flow cytometric data were analyzed by using FlowJo software
(Tree Star, Inc, Ashland, OR).
Cytokine production of human CD8
+ T cells stimulated
with PMA and ionomycin
The splenocytes of hNOK mice were cultured at a density of
1610
6 cells in 96- well plates with phorbol 12-myristate 13-acetate
(PMA) (10 ng/ml) and ionomycin (1 ng/ml). Two hours later,
brefeldin A (10 ng/ml) was added to each well. After a further 4-
hour incubation, the splenocytes were stained with Allophycocya-
nin-labeled anti-IL-2, FITC-labeled anti-IFN-c, and PE-Cy7-
labeled anti-TNF mAbs, and the stained cells were analyzed on
the FACSCant II flow cytometer.
Assay for alloreactivity of human CD8
+ T cells
PBMC (5610
6/mouse) from a healthy donor with HLA types
HLA-A*2402/A*2402, B*5201/B*5901, and DRB1*1502/
DRB1*0405 were irradiated and then intraperitoneally injected
into hNOK mice. At 4 weeks after the injection, PBMC and
splenocytes of the hNOK mice were harvested and analyzed for
their phenotype by using the FACSCant II. To investigate IFN-c
expression of human T cells against alloantigen, we cultured the
splenocytes for 6 hours at a density of 1610
6 cells in 96-well plates
with the irradiated PBMC or irradiated self-CB. Then the cultured
cells were stained with anti-CD3 mAb, anti-CD8 mAb, and anti-
IFN-c mAb. For proliferation assays, carboxyfluorescein diacetate
N-succinimidyl ester (CFSE, Molecular Probes, Willow Creek
Road Eugene, OR) for a final concentration of 0.5 mM was added
to the cell suspension. After a 15-min incubation, the excess CFSE
was removed by washing with 5% FCS/PBS; and then the cells
were resuspended in RPMI1640 containing 10% FCS. The
CFSE-labeled cells were cultured for 3 days with 721.221 cells
expressing HLA-A*2402 or HLA-B*5201 and then were analyzed
on the FACSCant II.
Statistical analysis
Results shown as bar graphs were expressed as the means 6
S.E.M. One-way ANOVA followed by Dunnet’s test was used for
multiple comparisons. Differences were considered to be statisti-
cally significant when the p-value was less than 0.05.
Supporting Information
Figure S1 Phenotypic analysis of reconstituted human CD8
+ T
cells stimulated with alloantigen in hNOK mice hNOK mice were
immunizedfor31dayswithirradiatedhumanPBMCfromahealthy
donor with HLA-A*2402/A*2402, HLA-B*5201/B*5901, and
HLA-DRB1*1502/DRB1*0405. Then the phenotype of human
CD8
+ T cells among PBMC from the hNOK mice was analyzed on
0, 7, and 31 days after the immunization. Splenocytes from the same
mice were examined at day 31. (A) Representative results of 5-color
flow cytometric analysis of CCR7CD45RACD27CD28 subsets
in human CD8
+ T cell population of PBMC and splenocytes
are shown. (B) Representative results for Per, GraA, and GraB
expression by the human CD8
+ T cells among splenocytes from the
hNOK mice are shown.
Found at: doi:10.1371/journal.pone.0013109.s001 (1.97 MB TIF)
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